Clinical Research Decision-Making Assistant

Clinical Research Decision-Making Assistant — Module 1

Clinical Research Decision-Making Assistant

Module 1 — Lesson 1: What is Clinical Research?  •  Lesson 2: The Clinical Research Process

How to use this tool

  1. Study Classifier: Describe your project (human subjects? interventional/observational?) to classify the study type.
  2. Process Mapper: Indicate product status to get a recommended phase and goals.
  3. Ethics & Governance: Generate a checklist (IRB/IEC, informed consent, DSMB, registration, etc.).
  4. Outputs: Auto-build a printable plan; copy or export JSON.
  5. Load Scenarios: Prefill with example cases for quick learning.
Educational use only. This assistant supports learning and planning. It does not replace sponsor/SOPs, IRB/IEC decisions, or regulatory advice.

Why it matters

Clinical research advances medical knowledge and patient care. Understanding fundamentals (definitions, phases, ethics) helps you choose the right design, protect participants, and meet regulatory expectations.

Historical milestones
1747 — James Lind’s scurvy trial 1940s — Nuremberg Code 1964 — Declaration of Helsinki
Core principles
Respect for persons Beneficence Justice

Study Classifier (Lesson 1)

Describe your study and get a classification + key components.

Classification & Guidance

Fill fields and click Classify to see results.
What this means
  • Interventional = You assign interventions → clinical trial protocol, safety monitoring, registration often required.
  • Observational = No assigned intervention → cohort, case-control, or cross-sectional designs.
  • Records/Biospecimens may be exempt/expedited in some jurisdictions but still require ethics review.

Process Mapper (Lesson 2)

Map your current status to a recommended phase and focus areas.

Recommended Step & Objectives

Choose options and click Map Process to view guidance.
Phases (quick refresher)
  • Phase I: Safety & dosage (often 20–80)
  • Phase II: Preliminary efficacy & safety (100–300)
  • Phase III: Confirmatory efficacy vs control; broader safety (hundreds–thousands)
  • Phase IV: Post-market surveillance & RWE

Ethics & Governance Checklist

Generate a tailored oversight plan.

Your Governance Plan

Select inputs and click Build Checklist.
Principles refresher

Respect for persons • Beneficence • Justice — implemented via informed consent, risk-benefit assessment, fair selection, and ongoing monitoring.

Load Example Scenarios

Use these to auto-populate fields for practice.

Diabetes drug — efficacy vs placebo

Interventional, RCT; prospective; first-in-human not done → Phase I/II path.

COVID-19 vaccine program

Interventional, randomized; sequential Phases I–III; robust Phase IV safety.

Historical — Scurvy (Lind)

Interventional, controlled diet arms; foundational trial design concepts.

Hypertension drug — Phase III

Large confirmatory RCT vs SOC; endpoints: blood pressure reduction.

Outputs

Your consolidated plan (print/copy/export).

Consolidated Plan

Run the Classifier, Process Mapper, and Ethics builder to populate this section.

Lesson Summaries

Lesson 1 — What is Clinical Research?
TopicContentExample
Definition of Clinical Research Studies with human subjects/human-origin materials to evaluate biomedical/health outcomes. Ranges from basic science to clinical trials & epidemiology. Trial testing a new diabetes drug for efficacy & safety in volunteers.
Importance Advances knowledge, improves care, develops treatments, clarifies disease, improves diagnostics/prevention, ensures safety/efficacy. COVID-19 vaccines built on rigorous clinical research.
Historical Background Lind’s scurvy trial (1747), Nuremberg Code (1940s), Declaration of Helsinki (1964). Lind’s grouped diet comparison pioneered trial design.
Key Components Protocol, participants (consent), data collection & analysis. Hypertension trial protocol specifies dose, duration, BP measures.
Ethical Considerations Respect for persons, Beneficence, Justice. Informed consent covering purpose, procedures, risks, benefits.
Lesson 2 — The Clinical Research Process

Overview

StepDescriptionExample
Preclinical Research Lab/cell/animal; efficacy, toxicity, PK. New cancer drug shrinks tumors in mice; assess side effects.
Clinical Trials Phases I–IV assess safety, efficacy, and real-world performance. Phase I antiviral in 20–80 volunteers; Phase II diabetes med (100–300); Phase III hypertension drug (1,000–3,000); Phase IV long-term safety.
Regulatory Review & Approval Submit comprehensive dossier (e.g., NDA/MAA). NDA to FDA for new pain medication.
Post-Market Surveillance Ongoing safety/efficacy monitoring; label updates. New statin gets warning updates after rare AEs detected.

Clinical Trial Phases

PhaseObjectiveParticipantsFocusExample
ISafety & dosage20–80MTD, PK, side effectsAntiviral in healthy volunteers
IIEfficacy & side effects100–300Preliminary efficacy + safetyDiabetes med lowers HbA1c
IIIConfirm efficacy vs standard; safetyHundreds–thousandsDefinitive endpointsHypertension drug vs placebo/SOC
IVPost-market safetyGeneral populationRare AEs, long-term effectsNew antidepressant RWE